Items 61 ~ 80 of 5552, Page 4 of 279    04/13/2019 WHO - Public Health At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices - WHO to continue to facilitate countries' information-sharing to improve transparency on prices   04/11/2019 U.S. FOOD & DRUG ADMINISTRATION - Government FDA orders important safety labeling changes for Addyi   04/03/2019 U.S. FOOD & DRUG ADMINISTRATION - Government Statement on FDA¡¯s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk, while progressing the agency¡¯s commitment to help advance legitimate stem cell product development under existing agency regulations   04/03/2019 U.S. FOOD & DRUG ADMINISTRATION - Government Statement on FDA¡¯s ongoing scientific investigation of potential safety issue related to seizures reported following e-cigarette use, particularly in youth and young adults   04/02/2019 U.S. FOOD & DRUG ADMINISTRATION - Government Statement on steps toward a new, tailored review framework for artificial intelligence-based medical devices   04/02/2019 Radiological Society of North America - Clinical Bariatric Embolization Shows Promise in Treatment of Obesity - Bariatric embolization, a new, minimally invasive treatment for obesity produces weight loss and reduces appetite for up to one year, according to a new study published in the journal Radiology.   04/01/2019 MERCK - Business Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1 - Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas / Selumetinib Is a MEK 1/2 Inhibitor Being Co-Developed by AstraZeneca and Merck   03/29/2019 U.S. FOOD & DRUG ADMINISTRATION - Government FDA approves new oral treatment for multiple sclerosis   03/27/2019 U.S. FOOD & DRUG ADMINISTRATION - Government FDA advances landmark policy changes to modernize mammography services and improve their quality - Proposed rule would require breast density reporting, enhance the FDA¡¯s ability to enforce mammography facilities¡¯ compliance with standards   03/26/2019 U.S. FOOD & DRUG ADMINISTRATION - Government FDA approves new oral drug to treat multiple sclerosis <<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  >  >> Go to Headlines